Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2'-deoxyadenosine (2-CdA) and Rituximab.
Rabascio C, Laszlo D, Andreola G, Saronni L, Radice D, Rigacci L, Fabbri A, Frigeri F, Calabrese L, Billio A, Bertolini F, Martinelli G. Rabascio C, et al. Among authors: radice d. Leuk Res. 2010 Apr;34(4):454-7. doi: 10.1016/j.leukres.2009.07.002. Epub 2009 Aug 3. Leuk Res. 2010. PMID: 19647871 Clinical Trial.
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas.
Ferrucci PF, Vanazzi A, Grana CM, Cremonesi M, Bartolomei M, Chinol M, Ferrari M, Radice D, Papi S, Martinelli G, Paganelli G. Ferrucci PF, et al. Among authors: radice d. Br J Haematol. 2007 Nov;139(4):590-9. doi: 10.1111/j.1365-2141.2007.06869.x. Br J Haematol. 2007. PMID: 17979944 Free article.
Tissue microarrays in diffuse large B-cell lymphomas: are they really able to identify distinct prognostic groups in lymphomas of both nodal and extranodal origin?
Laszlo D, Pruneri G, Andreola G, Radice D, Calabrese L, Rafaniello PR, Nassi L, Sammassimo S, Alietti A, Agazzi A, Vanazzi A, Martinelli G. Laszlo D, et al. Among authors: radice d. Int J Surg Pathol. 2011 Aug;19(4):417-24. doi: 10.1177/1066896909345596. Epub 2009 Sep 30. Int J Surg Pathol. 2011. PMID: 19793830
Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents.
Noberasco C, Spitaleri G, Mancuso P, Zorzino L, Radice D, Milani A, Rocca A, Bertolini F, Sandri MT, Curigliano G, de Pas T, Jemos C, Omodeo Salè E, Boselli S, de Braud F. Noberasco C, et al. Among authors: radice d. Oncology. 2009;77(6):358-65. doi: 10.1159/000275830. Epub 2010 Jan 11. Oncology. 2009. PMID: 20068365 Clinical Trial.
Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study.
Laszlo D, Andreola G, Rigacci L, Fabbri A, Rabascio C, Mancuso P, Pruneri G, Radice D, Pinto A, Frigeri F, Calabrese L, Billio A, Bertolini F, Martinelli G. Laszlo D, et al. Among authors: radice d. J Clin Oncol. 2010 May 1;28(13):2233-8. doi: 10.1200/JCO.2009.23.6315. Epub 2010 Apr 5. J Clin Oncol. 2010. PMID: 20368573 Clinical Trial.
159 results